{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:04:31Z","timestamp":1792461871479,"version":"4.5.0"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ijpddr.2020.11.006","type":"journal-article","created":{"date-parts":[[2020,12,13]],"date-time":"2020-12-13T07:07:27Z","timestamp":1607843247000},"page":"43-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions \u2013 India and sub-Saharan Africa"],"prefix":"10.1016","volume":"15","author":[{"given":"Aditi","family":"Arya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loick P.","family":"Kojom Foko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shewta","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineeta","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2020.11.006_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12936-018-2265-x","article-title":"Efficacy and safety of artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Sudan: a systematic review and meta - analysis","volume":"17","author":"Adam","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/IJTDH\/2018\/41204","article-title":"Past and current findings in antimalarial drug resistance molecular markers in endemic areas of Africa","volume":"30","author":"Adjekukor","year":"2018","journal-title":"Int J Trop Dis Health"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","article-title":"Genetic markers associated with dihydroartemisinin\u2013piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study","volume":"17","author":"Amato","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2229-5070.175081","article-title":"Antimalarial drug resistance: an overview","volume":"6","author":"Antony","year":"2016","journal-title":"Tropenmed. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A\u00a0molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib6","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(18)30324-6","article-title":"Malaria","volume":"391","author":"Ashley","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib7","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/infdis\/jir486","article-title":"Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with Artemether-Lumefantrine in Uganda","volume":"204","author":"Baliraine","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib8","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4269\/ajtmh.17-0436","article-title":"Distribution of mutations associated with antifolate and chloroquine resistance among imported Plasmodium vivax in the State of Qatar","volume":"97","author":"Bansal","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191922","article-title":"Impact of treatment and re-treatment with artemether-lumefantrine and artesunate- amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda","volume":"13","author":"Baraka","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12936-020-03290-w","article-title":"Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial","volume":"19","author":"Beavogui","year":"2020","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib11","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1016\/S2214-109X(17)30076-1","article-title":"Population coverage of artemisinin-based combination treatment in children younger than 5 years with fever and Plasmodium falciparum infection in Africa, 2003\u20132015: a modelling study using data from national surveys","volume":"5","author":"Bennett","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/27094","article-title":"Molecular biology: calcium - a life and death signal","volume":"395","author":"Berridge","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12936-016-1672-0","article-title":"Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea)","volume":"16","author":"Berzosa","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cell.2011.10.051","article-title":"Endoplasmic reticulum PI(3)P lipid binding targets malaria proteins to the host cell","volume":"148","author":"Bhattacharjee","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1126\/science.aax4735","article-title":"A\u00a0Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites","volume":"367","author":"Birnbaum","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm.4381","article-title":"Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic","volume":"23","author":"Blasco","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12936-020-03339-w","article-title":"Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in\u00a0vitro genotypic and phenotypic characterization","volume":"19","author":"Boonyalai","year":"2020","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib18","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/s41467-018-04104-z","article-title":"Plasmepsin II \u2013 III copy number accounts for bimodal","volume":"9","author":"Bopp","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2958.2005.04556.x","article-title":"Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance","volume":"56","author":"Bray","year":"2005","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.1215966","article-title":"A\u00a0major genome region underlying artemisinin resistance in malaria","volume":"335","author":"Cheeseman","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/279028","article-title":"Occurrence of pfatpase6 single nucleotide polymorphisms associated with Artemisinin resistance among field isolates of Plasmodium falciparum in North-Eastern Tanzania","volume":"2015","author":"Chilongola","year":"2015","journal-title":"Malar. Res. Treat."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006923","article-title":"How to combat emerging artemisinin resistance\u202f: lessons from \u201c the three little pigs","volume":"14","author":"Chookajorn","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib23","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","article-title":"Antimalarial drug resistance in Africa: the calm before the storm?","volume":"19","author":"Conrad","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib24","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1586\/eri.09.68","article-title":"Discovery, mechanisms of action and combination therapy of artemisinin","volume":"7","author":"Cui","year":"2009","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib25","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1128\/AAC.05943-11","article-title":"Lack of association of the S769N mutation in Plasmodium falciparum SERCA (PfATP6) with resistance to artemisinins","volume":"56","author":"Cui","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib26","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1128\/AAC.02762-14","article-title":"Double mutation in the pfmdr1 gene is associated with emergence of chloroquine-resistant Plasmodium falciparum malaria in Eastern India","volume":"58","author":"Das","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib27","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/cid\/ciy1038","article-title":"Novel pfkelch13 Gene polymorphism associates with Artemisinin resistance in Eastern India","volume":"69","author":"Das","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib28","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJMc1713777","article-title":"Evidence of artemisinin-resistant plasmodium falciparum malaria in eastern India","volume":"379","author":"Das","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12936-018-2290-9","article-title":"Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017","volume":"17","author":"Davlantes","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0030-1267062","article-title":"The random allocation process: two things you need to know","volume":"1","author":"Dettori","year":"2010","journal-title":"Evid. Base Spine Care J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib31","doi-asserted-by":"crossref","first-page":"8907","DOI":"10.1038\/s41598-020-65553-5","article-title":"Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal","volume":"10","author":"Diallo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01068-18","article-title":"Investigating the efficacy of triple artemisinin-based combination therapies for treating Plasmodium falciparum malaria patients using mathematical modeling","volume":"62","author":"Dini","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4269\/ajtmh.2008.78.455","article-title":"Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali","volume":"78","author":"Djimd\u00e9","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.actatropica.2005.04.008","article-title":"Contribution of the pfmdr1 gene to antimalarial drug-resistance","volume":"94","author":"Duraisingh","year":"2005","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib36","first-page":"13","article-title":"The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin","volume":"108","author":"Duraisingh","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib1a","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1365-2958.2004.04035.x","article-title":"Dissecting the loci of low-level quinine resistance in malaria parasites","volume":"52","author":"Ferdig","year":"2004","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1475-2875-12-255","article-title":"Selection of pfdhfr\/pfdhps alleles and declining artesunate\/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan","volume":"12","author":"Gadalla","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib38","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1128\/AAC.05102-11","article-title":"Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with Artemether-Lumefantrine","volume":"55","author":"Gadalla","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib39","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1128\/JCM.03437-12","article-title":"High prevalence of asymptomatic Malaria in a tribal population in Eastern India","volume":"51","author":"Ganguly","year":"2013","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib40","author":"Gogtay"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/pr.57.1.4","article-title":"Mechanisms of resistance of malaria parasites to antifolates","volume":"57","author":"Gregson","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12936-017-1814-z","article-title":"What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism","volume":"16","author":"Group","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","article-title":"Drug resistance in plasmodium","volume":"16","author":"Haldar","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib44","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1128\/AAC.00968-08","article-title":"Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by Artemether-Lumefantrine in Nigerian children with uncomplicated falciparum malaria","volume":"53","author":"Happi","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib2a","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/AAC.01243-08","article-title":"Plasmodium falciparum Na+\/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine","volume":"53","author":"Henry","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib45","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11655-019-3164-x","article-title":"Effects and mechanism of action of Artemisinin on mitochondria of Plasmodium berghei","volume":"26","author":"Hou","year":"2019","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib46","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12936-020-03410-6","article-title":"No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China-Myanmar border","volume":"19","author":"Huang","year":"2020","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib47","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3201\/eid2404.170141","article-title":"Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014-2016","volume":"24","author":"Ikeda","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib48","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3201\/eid2408.180370","article-title":"Plasmodium falciparum plasmepsin 2 duplications, West Africa","volume":"24","author":"Inoue","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib49","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5897\/AJPP2018.4942","article-title":"Plasmodium falciparum drug resistance gene status in the Horn of Africa\u202f: a systematic review","volume":"12","author":"Jalei","year":"2018","journal-title":"Afr. J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib50","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0140-6736(05)67787-2","article-title":"Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6","volume":"366","author":"Jambou","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib51","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12936-018-2524-x","article-title":"Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania","volume":"17","author":"Kakolwa","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1475-2875-11-58","article-title":"Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania","volume":"11","author":"Kamugisha","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1128\/AAC.00498-09","article-title":"Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malari","volume":"54","author":"Karema","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib54","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1111\/febs.14097","article-title":"Oxidative stress in malaria and artemisinin combination therapy\u202f: pros and Cons","volume":"284","author":"Kavishe","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib55","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s12936-015-1018-3","article-title":"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola","volume":"14","author":"Kiaco","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib56","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1242\/jcs.104.4.1129","article-title":"Cloning of a Ca2+-ATPase gene of Plasmodium falciparum and comparison with vertebrate Ca2+-ATPases","volume":"104","author":"Kimura","year":"1993","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib57","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1073\/pnas.1217452110","article-title":"Altered temporal response of malaria parasites determines differential sensitivity to artemisinin","volume":"110","author":"Klonis","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib58","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1128\/AAC.44.8.2100-2108.2000","article-title":"Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site","volume":"44","author":"Korsinczky","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib59","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12936-019-2976-7","article-title":"Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against","volume":"18","author":"Krishna","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib60","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pt.2013.04.001","article-title":"Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy","volume":"29","author":"Krishna","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib61","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.meegid.2015.08.027","article-title":"Emergence of sulfadoxine-pyrimethamine resistance in Indian isolates of Plasmodium falciparum in the last two decades","volume":"36","author":"Kumar","year":"2015","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib62","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa062032","article-title":"Return of chloroquine antimalarial efficacy in Malawi","volume":"355","author":"Laufer","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib63","first-page":"54","article-title":"Limited artemisinin resistance-associated polymorphisms in Plasmodium falciparum K13-propeller and PfATPase6 gene isolated from Bioko Island, Equatorial Guinea","volume":"6","author":"Li","year":"2016","journal-title":"Int. J. Parasitol.: Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib64","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12936-019-3089-z","article-title":"In\u00a0vivo\/ex\u00a0vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso","volume":"19","author":"Lingani","year":"2020","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib65","first-page":"16","article-title":"Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine","volume":"9","author":"Loesbanluechai","year":"2019","journal-title":"Int. J. Parasitol.: Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib66","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMc1612765","article-title":"Emergence of indigenous artemisinin-resistant plasmodium falciparum in Africa","volume":"376","author":"Lu","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib67","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/2229-5070.248695","article-title":"Drug susceptibility testing methods of antimalarial agents","volume":"8","author":"Maji","year":"2018","journal-title":"Tropenmed. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib68","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/infdis\/jis747","article-title":"Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms","volume":"207","author":"Malmberg","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib69","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nature14412","article-title":"A\u00a0molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria","volume":"520","author":"Mbengue","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib70","series-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","first-page":"4320","article-title":"Antimalarial drugs","author":"McCarthy","year":"2015"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib71","doi-asserted-by":"crossref","first-page":"a025619","DOI":"10.1101\/cshperspect.a025619","article-title":"Antimalarial drug resistance: a threat to malaria elimination","volume":"7","author":"Menard","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib72","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","article-title":"A\u00a0worldwide map of Plasmodium falciparum K13-Propeller polymorphisms","volume":"374","author":"M\u00e9nard","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib73","series-title":"Guide de prise en charge du paludisme au Cameroun. A l\u2019usage du personnel de sant\u00e9","author":"Ministere de la Sante Publique","year":"2019"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib74","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/1475-2875-13-284","article-title":"Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India","volume":"13","author":"Mishra","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib75","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2471\/BLT.12.109124","article-title":"Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009 \u2013 2010","volume":"90","author":"Mishra","year":"2012","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib76","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1128\/AAC.04632-14","article-title":"Surveillance of artemisinin resistance in Plasmodium falciparum in India using the kelch13 molecular marker","volume":"59","author":"Mishra","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib77","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/20477724.2017.1331875","article-title":"Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012\u20132014","volume":"111","author":"Mishra","year":"2017","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib79","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1475-2875-10-123","article-title":"High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine- pyrimethamine treatment failures in\u00a0vivo in Gabonese children","volume":"10","author":"Mombo-ngoma","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib80","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1128\/AAC.00882-09","article-title":"Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors","volume":"53","author":"Moura","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib81","doi-asserted-by":"crossref","first-page":"e02309","DOI":"10.1128\/AAC.02309-17","article-title":"Inactivation of plasmepsins 2 and 3 sensitizes Plasmodium falciparum to the antimalarial drug piperaquine","volume":"62","author":"Mukherjee","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib82","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.pt.2013.08.002","article-title":"Mapping \u2018 partially resistant \u2019, \u2018 fully resistant \u2019, and \u2018 super resistant \u2019 malaria","volume":"29","author":"Naidoo","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib83","first-page":"135","article-title":"Polymorphism in dhfr\/dhps genes, parasite density and ex\u00a0vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal","volume":"3","author":"Ndiaye","year":"2013","journal-title":"Int. J. Parasitol.: Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib84","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/cid\/cir066","article-title":"Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children < 5 years of age with acute uncomplicated plasmodium falciparum malaria in rural Tanzania: a randomized trial","volume":"52","author":"Ngasala","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib85","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1475-2875-10-64","article-title":"Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania\u202f: an open label prospective study","volume":"10","author":"Ngasala","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib86","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence of artemisinin-resistant malaria in Western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib87","first-page":"26","article-title":"Resistance to artemisinin combination therapies (ACTs): do not forget the partner drug\u202f!","volume":"4","author":"Nsanzabana","year":"2019","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib88","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1038\/s41598-017-06708-9","article-title":"Mapping sulphadoxine- Plasmodium falciparum malaria in infected humans and in parasite populations in Africa","volume":"7","author":"Okell","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib89","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1038\/s41598-017-06708-9","article-title":"Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa","volume":"7","author":"Okell","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib90","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12936-016-1503-3","article-title":"Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate \u2013 amodiaquine fixed dose combination or artemether \u2013 lumefantrine in Liberia","volume":"15","author":"Otienoburu","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib91","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1051\/parasite\/2018021","article-title":"Plasmodium falciparum resistance to artemisinin-based combination therapies\u202f: a sword of Damocles in the path toward malaria elimination","volume":"24","author":"Ouji","year":"2018","journal-title":"Parasite"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib92","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12936-016-1206-9","article-title":"Plasmodium falciparum\u202f: multifaceted resistance to artemisinins","volume":"15","author":"Paloque","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib93","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00436-018-6126-x","article-title":"Current scenario and future strategies to fight artemisinin resistance","volume":"118","author":"Pasupureddy","year":"2019","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib94","doi-asserted-by":"crossref","first-page":"16690","DOI":"10.1038\/s41598-017-16866-5","article-title":"Prevalence of mutations linked to antimalarial resistance in Plasmodium falciparum from Chhattisgarh, Central India: a malaria elimination point of view","volume":"7","author":"Patel","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib95","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","article-title":"Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria","volume":"85","author":"Peterson","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib96","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1128\/AAC.47.8.2418-2423.2003","article-title":"Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1","volume":"47","author":"Pickard","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib97","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12936-017-1712-4","article-title":"Efficacy of artemether \u2013lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola","volume":"16","author":"Plucinski","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib98","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","article-title":"Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis","volume":"14","author":"Price","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib99","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.pt.2018.01.001","article-title":"Evolutionary ARMS race: antimalarial resistance molecular surveillance","volume":"34","author":"Prosser","year":"2018","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib100","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/cid\/ciz166","article-title":"Lack of convincing evidence of artemisinin resistance in India","volume":"69","author":"Rasmussen","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib101","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12936-017-1925-6","article-title":"Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination","volume":"16","author":"Recht","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00374-18","article-title":"Absence of a high level of duplication of the plasmepsin II gene in Africa","volume":"62","author":"Robert","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib103","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41467-018-05652-0","article-title":"Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine","volume":"9","author":"Ross","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molbiopara.2017.08.003","article-title":"Presence of quintuple dhfr N51, C59, S108 \u2013 dhps A437, K540 mutations in Plasmodium falciparum isolates from pregnant women and the general population in Nanoro, Burkina Faso","volume":"217","author":"Ruizendaal","year":"2017","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib105","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1128\/AAC.05388-11","article-title":"Comparative efficacies of Artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt , pfdhfr , and pfdhps genes in Tea Gardens of Jalpaiguri District, India","volume":"56","author":"Saha","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib3a","first-page":"913","article-title":"pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum","volume":"57","author":"Sidhu","year":"2005","journal-title":"Mol. Biol."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib106","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/0255-0857.180298","article-title":"Mutational prevalence of chloroquine resistance transporter gene among Plasmodium falciparum field isolates in Assam and Arunachal Pradesh, India","volume":"34","author":"Sharma","year":"2016","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib107","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1126\/science.1074045","article-title":"Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations","volume":"298","author":"Singh Sidhu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib108","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.actatropica.2018.06.016","article-title":"Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone","volume":"185","author":"Smith","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib109","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/AAC.01413-09","article-title":"Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine\/sulfadoxine-pyrimethamine , but not by dihydroartemisinin-piperaquine in Burkina Faso","volume":"54","author":"Som\u00e9","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151565","article-title":"Artesunate-amodiaquine and artemether-lumefantrine therapies and selection of pfcrt and Pfmdr1 alleles in Nanoro, Burkina Faso","volume":"11","author":"Sondo","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib4a","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpddr.2015.07.001","article-title":"The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs","volume":"27","author":"Spillman","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib111","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1475-2875-9-247","article-title":"Anti-folate drug resistance in Africa\u202f: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations","volume":"9","author":"Sridaran","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib112","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1475-2875-12-247","article-title":"A\u00a0clinical and molecular study of artesunate\u00a0+ sulphadoxine-pyrimethamine in three districts of central and eastern India","volume":"12","author":"Srivastava","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib113","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib114","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/EC.00124-10","article-title":"Phosphatidylinositol 3-phosphate, an essential lipid in Plasmodium, localizes to the food vacuole membrane and the apicoplast","volume":"9","author":"Tawk","year":"2010","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib115","article-title":"CheCklist for randomized controlled trials: critical appraisal tools for use in JBI systematic reviews","year":"2020","journal-title":"JBI Syst. Rev."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib116","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.94.25.13944","article-title":"Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum","volume":"94","author":"Triglia","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib117","series-title":"Artemisinin \u2014 A Gift from Traditional Chinese Medicine to the World","author":"Tu","year":"2015"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in\u00a0vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","author":"Uwimana","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib119","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib120","doi-asserted-by":"crossref","first-page":"10111","DOI":"10.1038\/ncomms10111","article-title":"Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib121","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/tmi.12458","article-title":"Treatment of uncomplicated malaria with artesunate plus sulfadoxine \u2013 pyrimethamine is failing in Somalia\u202f: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles","volume":"20","author":"Warsame","year":"2015","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib122","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/tmi.12847","article-title":"Efficacy of artesunate\u00a0+ sulphadoxine\/pyrimethamine and artemether\u00a0+ lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy","volume":"22","author":"Warsame","year":"2017","journal-title":"Trop. Med. Int."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40268-018-0259-3","article-title":"Monitoring the efficacy and safety of artemisinin-based combination therapies: a review and network meta-analysis of antimalarial therapeutic efficacy trials in Cameroon","volume":"19","author":"Whegang","year":"2019","journal-title":"Drugs R"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib124","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12936-019-2955-z","article-title":"Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance","volume":"18","author":"White","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib125","first-page":"1608","article-title":"Malaria","volume":"391","author":"White","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib126","series-title":"World Malaria Report 2020","first-page":"166","author":"WHO","year":"2020"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib127","series-title":"World Malaria Report 2019","first-page":"232","author":"WHO","year":"2019"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib128","series-title":"World Malaria Report 2018","first-page":"210","author":"WHO","year":"2018"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib129","series-title":"Artemisinin Resistance and Artemisinin-Based Combination Therapy Efficacy","author":"WHO","year":"2018"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib130","series-title":"Global Technical Strategy for Malaria 2016\u20132030","author":"WHO","year":"2016"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib131","series-title":"Technical Report Series. Chemotherapy of Malaria","author":"WHO","year":"1967"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib132","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","article-title":"A\u00a0surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype\u2013genotype association study","volume":"17","author":"Witkowski","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib133","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1128\/AAC.01868-12","article-title":"Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in Western Cambodia","volume":"57","author":"Witkowski","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib134","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.01636-09","article-title":"Increased tolerance to Artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism","volume":"54","author":"Witkowski","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib135","series-title":"Artemisinin Resistance and Artemisinin-Based Combination Therapy Efficacy","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.ijpddr.2020.11.006_bib136","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1128\/AAC.03494-14","article-title":"Role of Pfmdr1 in in\u00a0vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin","volume":"58","author":"Wurtz","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib137","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.celrep.2019.10.095","article-title":"Decreased K13 abundance reduces hemoglobin catabolism and proteotoxic stress, underpinning artemisinin resistance","volume":"29","author":"Yang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib138","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/jiv551","article-title":"Artesunate\/Amodiaquine versus Artemether\/Lumefantrine for the treatment of uncomplicated malaria in Uganda\u202f: a randomized trial","volume":"213","author":"Yeka","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.11.006_bib139","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00436-016-5353-2","article-title":"Risk of drug resistance in Plasmodium falciparum malaria therapy \u2014 a systematic review and meta-analysis","volume":"116","author":"Zhou","year":"2016","journal-title":"Parasitol. Res."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:52:05Z","timestamp":1761922325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320720300488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":143,"alternative-id":["S2211320720300488"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.11.006","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions \u2013 India and sub-Saharan Africa","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}